share_log

Immunocore-晚期皮肤黑色素瘤的单一疗法 Brenetafusp 表现出良好的无进展存活率和 ctdna 分子反应

Immunocore-monotherapy for advanced cutaneous melanoma, Brenetafusp showed good progression-free survival and ctDNA molecular response

Zhitong Finance ·  Jun 1 04:06
Immunocore-monotherapy for advanced cutaneous melanoma, Brenetafusp showed good progression-free survival and ctDNA molecular response

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment